4-Methylmorpholine
SIAL/67870 - purum, ≥98.0% (GC)
Synonym: N-Methylmorpholine; NMM
CAS Number: 109-02-4
Empirical Formula (Hill Notation): C5H11NO
Molecular Weight: 101.15
EC Number: 203-640-0
MDL Number: MFCD00006175
Linear Formula: C5H11NO
Product Type: Chemical
| assay | ≥98.0% (GC) |
| bp | 115-116 °C/750 mmHg (lit.) |
| density | 0.918 g/mL at 20 °C |
| 0.92 g/mL at 25 °C (lit.) | |
| grade | purum |
| InChI | 1S/C5H11NO/c1-6-2-4-7-5-3 |
| InChI key | SJRJJKPEHAURKC-UHFFFAOYSA |
| mp | −66 °C (lit.) |
| Quality Level | 200  |
| refractive index | n |
| n |
|
| SMILES string | CN1CCOCC1 |
| vapor density | >1 (vs air) |
| vapor pressure | 18 mmHg ( 20 °C) |
| Application: | 4-Methylmorpholine(NMM) has been used for amidation of hyaluronic acid to synthesize its derivative with potential applications in hydrogel synthesis and gold coatings. NMM can be used as a reactant for the synthesis of: • 1-Butyl-1-methylmorphol • Quaternary ammonium complexes that can be used as complexing agents in redox flow batteries (RFBs). It can also be used as an activating reagent: • For the synthesis of peptide-drug conjugate for targeted drug delivery. • To synthesize acrylate star polymers with application as magnetic resonance imaging (MRI) agents. |
| Symbol |    GHS02,GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H225 - H302 - H314 |
| Precautionary statements | P210 - P280 - P301 + P312 + P330 - P303 + P361 + P353 - P305 + P351 + P338 + P310 |
| Hazard Codes | F,C |
| Risk Statements | 11-22-34 |
| Safety Statements | 16-26-36/37/39-45 |
| RIDADR | UN 2535 8(3) / PGII |
| WGK Germany | WGK 1 |
| Flash Point(F) | 53.6 °F - DIN 51755 Part 1 |
| Flash Point(C) | 12 °C - DIN 51755 Part 1 |
| Purity | ≥98.0% (GC) |
| bp | 115-116 °C/750 mmHg (lit.) |
| mp | −66 °C (lit.) |
| Density | 0.918 g/mL at 20 °C; 0.92 g/mL at 25 °C (lit.) |
| Refractive Index | n |
| UNSPSC | 12352100 |